Literature DB >> 21576325

Expression of the type 1 pneumococcal pilus is bistable and negatively regulated by the structural component RrgA.

Alan Basset1, Keith H Turner, Elizabeth Boush, Sabina Sayeed, Simon L Dove, Richard Malley.   

Abstract

The pneumococcal type 1 pilus, which is present in 25 to 30% of clinical isolates, has been associated with increased adherence and inflammatory responses and is being evaluated as a potential vaccine candidate. Here we show that expression of the pilus is bistable as a result of the molecular interaction between the transcription activator RrlA and a structural component of the pilus called RrgA. Sampling various clinical pneumococcal isolates that harbor the type 1 pilus-encoding islet, we show that distinct populations of cells can be identified with either undetectable or prominent pilus expression. When these two populations are separated and regrown in liquid medium, they are phenotypically different: the nonexpressing population reverts to the previous bimodal distribution, whereas the expressing population retains the same high level of pilus expression. Controlled exogenous expression of the regulatory pilus gene rlrA in a strain from which the endogenous version has been deleted increases pilus expression steadily, suggesting that the bistable expression of the pilus observed in wild-type cells is dependent on the native rlrA promoter. Finally, we demonstrate that RrgA is a negative regulator of pilus expression and that this repression is likely mediated through direct interaction with RlrA. We conclude that type 1 pilus expression in pneumococcus exhibits a bistable phenotype, which is dependent upon the molecular interplay between the RlrA and RrgA proteins. We suggest that this flexibility in expression may assist adaptation to a range of immune conditions, such as evasion of antipilus antibodies, within potential hosts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576325      PMCID: PMC3147576          DOI: 10.1128/IAI.05117-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Molecular architecture of Streptococcus pneumoniae TIGR4 pili.

Authors:  Markus Hilleringmann; Philippe Ringler; Shirley A Müller; Gabriella De Angelis; Rino Rappuoli; Ilaria Ferlenghi; Andreas Engel
Journal:  EMBO J       Date:  2009-12-16       Impact factor: 11.598

3.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

4.  Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells.

Authors:  Heather C Maisey; Mary Hensler; Victor Nizet; Kelly S Doran
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

5.  Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.

Authors:  Priya Balachandran; Alexis Brooks-Walter; Anni Virolainen-Julkunen; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae.

Authors:  C K Sung; H Li; J P Claverys; D A Morrison
Journal:  Appl Environ Microbiol       Date:  2001-11       Impact factor: 4.792

7.  Local and global regulators linking anaerobiosis to cupA fimbrial gene expression in Pseudomonas aeruginosa.

Authors:  Isabelle Vallet-Gely; Josh S Sharp; Simon L Dove
Journal:  J Bacteriol       Date:  2007-09-21       Impact factor: 3.490

8.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

9.  H-NS family members function coordinately in an opportunistic pathogen.

Authors:  Sandra Castang; Heather R McManus; Keith H Turner; Simon L Dove
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-21       Impact factor: 11.205

10.  Epigenetic control of virulence gene expression in Pseudomonas aeruginosa by a LysR-type transcription regulator.

Authors:  Keith H Turner; Isabelle Vallet-Gely; Simon L Dove
Journal:  PLoS Genet       Date:  2009-12-18       Impact factor: 5.917

View more
  21 in total

1.  An epigenetic switch mediates bistable expression of the type 1 pilus genes in Streptococcus pneumoniae.

Authors:  Alan Basset; Keith H Turner; Elizabeth Boush; Sabina Sayeed; Simon L Dove; Richard Malley
Journal:  J Bacteriol       Date:  2011-12-22       Impact factor: 3.490

2.  Association of Pneumococcal Protein Antigen Serology With Age and Antigenic Profile of Colonizing Isolates.

Authors:  Taj Azarian; Lindsay R Grant; Maria Georgieva; Laura L Hammitt; Raymond Reid; Stephen D Bentley; David Goldblatt; Mathuran Santosham; Robert Weatherholtz; Paula Burbidge; Novalene Goklish; Claudette M Thompson; William P Hanage; Kate L O'Brien; Marc Lipsitch
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

3.  The Pneumococcal Type 1 Pilus Genes Are Thermoregulated and Are Repressed by a Member of the Snf2 Protein Family.

Authors:  Alan Basset; Muriel Herd; Raecliffe Daly; Simon L Dove; Richard Malley
Journal:  J Bacteriol       Date:  2017-07-11       Impact factor: 3.490

4.  Toll-like receptor (TLR) 2 mediates inflammatory responses to oligomerized RrgA pneumococcal pilus type 1 protein.

Authors:  Alan Basset; Fan Zhang; Cyril Benes; Sabina Sayeed; Muriel Herd; Claudette Thompson; Douglas T Golenbock; Andrew Camilli; Richard Malley
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

5.  Immune exclusion by naturally acquired secretory IgA against pneumococcal pilus-1.

Authors:  Ulrike Binsker; John A Lees; Alexandria J Hammond; Jeffrey N Weiser
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 6.  Panel 6: Vaccines.

Authors:  Stephen I Pelton; Melinda M Pettigrew; Stephen J Barenkamp; Fabrice Godfroid; Carlos G Grijalva; Amanda Leach; Janak Patel; Timothy F Murphy; Sanja Selak; Lauren O Bakaletz
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

Review 7.  Serotype-independent pneumococcal vaccines.

Authors:  Eliane Namie Miyaji; Maria Leonor Sarno Oliveira; Eneas Carvalho; Paulo Lee Ho
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

8.  The metal ion-dependent adhesion site motif of the Enterococcus faecalis EbpA pilin mediates pilus function in catheter-associated urinary tract infection.

Authors:  Hailyn V Nielsen; Pascale S Guiton; Kimberly A Kline; Gary C Port; Jerome S Pinkner; Fabrice Neiers; Staffan Normark; Birgitta Henriques-Normark; Michael G Caparon; Scott J Hultgren
Journal:  MBio       Date:  2012-07-24       Impact factor: 7.867

9.  Pilus adhesin RrgA interacts with complement receptor 3, thereby affecting macrophage function and systemic pneumococcal disease.

Authors:  Sofia Orrskog; Samuli Rounioja; Tiziana Spadafina; Marilena Gallotta; Martin Norman; Karina Hentrich; Stefan Fälker; Sofia Ygberg-Eriksson; Mike Hasenberg; Björn Johansson; Liisa M Uotila; Carl G Gahmberg; Michèle Barocchi; Matthias Gunzer; Staffan Normark; Birgitta Henriques-Normark
Journal:  MBio       Date:  2012-12-26       Impact factor: 7.867

10.  Expression of the Streptococcus pneumoniae pilus-1 undergoes on and off switching during colonization in mice.

Authors:  Laura Pancotto; Gabriella De Angelis; Esmeralda Bizzarri; Michèle A Barocchi; Giuseppe Del Giudice; Monica Moschioni; Paolo Ruggiero
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.